Notis Mc Conarty Edward Novo Nordisk A S Transaction History

Notis Mc Conarty Edward

$214 Million
Q3 2025

A detailed history of Notis Mc Conarty Edward transactions in Novo Nordisk A S stock. As of the latest transaction made, Notis Mc Conarty Edward holds 20,525 shares of NVO stock, worth $994,641. This represents 0.53% of its overall portfolio holdings.

Number of Shares

20,525

Previous 18,950 8.31%

Holding current value

$994,641

Previous $1.31 Million 12.93%

% of portfolio

0.53%

Previous 0.65%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$45.38 - $71.7 $71,473 - $112,927	1,575 Added 8.31%	20,525 $1.14 Million
Q2 2025 Jul 23, 2025	BUY	$58.08 - $81.05 $844,483 - $1.18 Million	14,540 Added 329.71%	18,950 $1.31 Million
Q1 2025 May 06, 2025	BUY	$69.3 - $90.95 $305,613 - $401,089	4,410 New	4,410 $306,000
Q3 2024 Nov 12, 2024	SELL	$119.07 - $145.42 $35,721 - $43,625	-300 Reduced 11.54%	2,300 $273,000
Q2 2024 Aug 12, 2024	SELL	$122.71 - $146.91 $49,084 - $58,764	-400 Reduced 13.33%	2,600 $371,000

Q1 2024 Apr 29, 2024	SELL	$102.11 - $135.92 $32,675 - $43,494	-320 Reduced 9.64%	3,000 $385,000
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $15,800 - $18,981	-180 Reduced 5.14%	3,320 $343,000
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $145,504 - $319,264	1,600 Added 84.21%	3,500 $318,000
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $15,597 - $17,265	-100 Reduced 5.0%	1,900 $307,000
Q4 2022 Feb 09, 2023	SELL	$102.55 - $135.33 $20,510 - $27,066	-200 Reduced 9.09%	2,000 $270,000
Q2 2022 Jul 19, 2022	SELL	$103.24 - $121.81 $20,648 - $24,362	-200 Reduced 8.33%	2,200 $245,000
Q4 2021 Feb 08, 2022	SELL	$95.88 - $117.08 $9,588 - $11,708	-100 Reduced 4.0%	2,400 $269,000
Q3 2021 Nov 10, 2021	BUY	$84.42 - $106.62 $211,050 - $266,550	2,500 New	2,500 $240,000

Others Institutions Holding NVO

# of Institutions

1,697

Shares Held

303M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Notis Mc Conarty Edward, based on Form 13F filings with the SEC.

News

Stay updated on Notis Mc Conarty Edward with notifications on news.

Account

Notis Mc Conarty Edward Novo Nordisk A S Transaction History